Overexpression of CMTM7 inhibits cell growth and migration in liver cancer
Zi-Ming Huang1,2, Peng-Ling Li3, Peng Yang1
1Department of Emergency Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Abstract:
Chemokine-like factor (CKLF)-like, MAL and related proteins for vesicle trafficking and membrane link (MARVEL) transmembrane domain-containing family proteins (CMTMs) have significant roles in the immune system, in male reproduction, as well as in tumorigenesis. Previous studies have shown that CMTM family member 7 (CMTM7) was broadly expressed in various normal tissues, but not in lung, gastric, esophageal, pancreas, and cervix cancers. To explore its relationship with liver cancer, we examined the expression of CMTM7 in liver cancers and its correlation with clinical and pathological conditions. We found that CMTM7 expression was markedly reduced in liver cancer tissues, and negatively correlated with TNM staging and tumor metastasis. In vitro studies showed that enforced expression of CMTM7 inhibited the cell growth and migration of liver cancer cells. Further analysis revealed that CMTM7 suppressed AKT signaling and induced cell cycle arrest at the G0/G1 phase in the liver cancer cells, likely as the consequent of decreased levels of cyclin D1, cyclin-dependent kinase 4 (CDK4), and CDK6, and increased p27 expression. Thus, CMTM7 functions as a tumor suppressor in liver cancer through suppressing cell cycle progression.
Insights
Chemokine-like factor-like (CMTM) family member 7 (CMTM7) is reduced in liver cancer, inhibiting tumor growth and metastasis. Enforced CMTM7 expression suppresses AKT signaling, leading to cell cycle arrest and acting as a tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Chemokine-like factor (CKLF)-like, MAL and related proteins for vesicle trafficking and membrane link (MARVEL) transmembrane domain-containing family proteins (CMTMs) are involved in immunity, reproduction, and tumorigenesis.
- CMTM family member 7 (CMTM7) is expressed in normal tissues but often absent in various cancers.
- The role of CMTM7 in liver cancer remains largely unexplored.
Purpose of the Study:
- To investigate the expression of CMTM7 in liver cancer tissues.
- To determine the correlation between CMTM7 expression and clinical-pathological features of liver cancer.
- To elucidate the functional role and molecular mechanisms of CMTM7 in liver cancer progression.
Main Methods:
- Analysis of CMTM7 expression in liver cancer tissues and correlation with TNM staging and metastasis.
- In vitro studies involving enforced expression of CMTM7 in liver cancer cell lines.
- Investigation of CMTM7's effects on AKT signaling, cell cycle progression, and expression of related proteins (cyclins, CDKs, p27).
Main Results:
- CMTM7 expression was significantly reduced in liver cancer tissues.
- Reduced CMTM7 expression negatively correlated with advanced TNM staging and tumor metastasis.
- Enforced CMTM7 expression inhibited liver cancer cell growth and migration by suppressing AKT signaling and inducing G0/G1 cell cycle arrest via modulation of cyclin D1, CDK4, CDK6, and p27 levels.
Conclusions:
- CMTM7 functions as a tumor suppressor in liver cancer.
- Downregulation of CMTM7 contributes to liver cancer progression by promoting cell cycle progression and metastasis.
- CMTM7 may represent a potential therapeutic target for liver cancer treatment.
More Related Videos
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Feedback Inhibition
Chemotaxis and Direction of Cell Migration
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
